Drug development: Through the barrier

Sarah DeWeerdt
Additional contact information
Sarah DeWeerdt: Sarah DeWeerdt is a freelance science writer based in Seattle, Washington.

Nature, 2016, vol. 537, issue 7621, S154-S157

Abstract: Treatments that can cross the blood–brain barrier are needed if doctors are to treat the devastating neurological symptoms of many lysosomal storage disorders.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/537S154a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:537:y:2016:i:7621:d:10.1038_537s154a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/537S154a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().